Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures

British Journal of Surgery

Volumn 95, Issue 6, 2008, Pages 727-734

  Erdogan, D ^a   Kloek, J J ^a   Ten Kate, F J W ^a   Rauws, E A J ^a   Busch, O R C ^a   Gouma, D J ^a   Van Gulik, T M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; BILE DUCT TUMOR; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; MIDDLE AGED; OBSTRUCTIVE JAUNDICE; PANCREATITIS; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; AUTOIMMUNE DISEASES; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CHOLESTASIS, EXTRAHEPATIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATITIS; PROGNOSIS;

EID: 44249100917     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6057     Document Type: Article

References (33)

1. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
2. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006; 13: 872-880.
3. Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg 1985; 72: 659-661.
4. Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosnia A, Gouma DJ. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 2001; 88: 48-51.
5. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161: 57-62.
6. Koea J, Holden A, Chau K, McCall J. Differential diagnosis of stenosing lesions at the hepatic hilus. World J Surg 2004; 28: 466-470.
7. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc 2005; 62: 152-157.
8. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-44.
9. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-2676.
10. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140: 170-178.
11. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;ζ22: 387-395.
12. Knoefel WT, Prenzel KL, Peiper M, Hosch SB, Gundlach M, Eisenberger CF et al. Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol 2003; 29: 658-661.
13. van Gulik TM, Gouma DJ. Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 2007; 14: 1969-1971.
14. Joyce AM, Kochman ML. Update on biliary endoscopy. Curr Opin Gastroenterol 2005; 21: 354-358.
15. Weber SM, Cubukcu-Dimopulo O, PalestyJA, Suriawinata A, KJimstra D, Brennan MF et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7: 129-137.
16. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003; 237: 853-858.
17. Morell A, Skvaril F, van Loghem E, Kleemola M. Human IgG subclasses in maternal and fetal serum. Vox Sang 1971; 21:481-492.
18. Van der Zee JS, Aalberse RC. Immunochemical characteristics of IgG4 antibodies. N Engl Reg Allergy Proc 1988;9:31-33.
19. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002; 105: 9-19.
20. Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2006; 367: 181-184.
21. Aalberse RC, Van Milligan F, Tan KY, Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy 1993; 48: 559-569.
22. Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 1992; 148:2731-2737.
23. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005; 31: 28-31.
24. Horiuchi A, Kawa S, Hamano H, Ochi Y, Kiyosawa K. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: report of 2 case reports and review. Gastrointest Endosc 2001; 53: 518-522.
25. Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 263-268.
26. Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000; 95: 2788-2794.
27. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
28. Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 683-687.
29. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-984.
30. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4: 23.
31. Kuroiwa T, Suda T, Takahashi T, Hirono H, Natsui M, Motoyama H et al. Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci 2002; 47: 1810-1816.
32. Vos PM, van Beek EJ, Smits NJ, Rauws EA, Gouma DJ, Reeders JW. Percutaneous balloon dilatation for benign hepaticojejunostomy strictures. Abdom Imaging 2000; 25: 134-138.
33. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-933.